Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Martiniello-Wilks

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cytotherapy|April 28, 2007
Cell and gene therapy in AustraliaR Martiniello-Wilks, J E J Rasko
Gene Therapy|October 24, 2014
The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissueD Gerace, R Martiniello-Wilks, B A O'Brien, et al.
Gene Therapy|June 1, 2002
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse modelsD Voeks, R Martiniello-Wilks, V Madden, et al.
Human Gene Therapy|August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsR Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerP J Russell, K T Ow, P N Tam, et al.
Gene Therapy|September 3, 2004
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirusX Y Wang, R Martiniello-Wilks, J M Shaw, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cytotherapy|April 28, 2007
Cell and gene therapy in AustraliaR Martiniello-Wilks, J E J Rasko
Gene Therapy|October 24, 2014
The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissueD Gerace, R Martiniello-Wilks, B A O'Brien, et al.
Gene Therapy|June 1, 2002
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse modelsD Voeks, R Martiniello-Wilks, V Madden, et al.
Human Gene Therapy|August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsR Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancerP J Russell, K T Ow, P N Tam, et al.
Gene Therapy|September 3, 2004
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirusX Y Wang, R Martiniello-Wilks, J M Shaw, et al.
Pageof 1